Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

The COX-2 specific inhibitor, valdecoxib, is an effective, opioid-sparing analgesic in patients undergoing total knee arthroplasty.

Reynolds LW, Hoo RK, Brill RJ, North J, Recker DP, Verburg KM.

J Pain Symptom Manage. 2003 Feb;25(2):133-41.

PMID:
12590029
2.
3.

Parecoxib sodium, a parenteral cyclooxygenase 2 selective inhibitor, improves morphine analgesia and is opioid-sparing following total hip arthroplasty.

Malan TP Jr, Marsh G, Hakki SI, Grossman E, Traylor L, Hubbard RC.

Anesthesiology. 2003 Apr;98(4):950-6.

PMID:
12657858
4.

Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery.

Ott E, Nussmeier NA, Duke PC, Feneck RO, Alston RP, Snabes MC, Hubbard RC, Hsu PH, Saidman LJ, Mangano DT; Multicenter Study of Perioperative Ischemia (McSPI) Research Group; Ischemia Research and Education Foundation (IREF) Investigators.

J Thorac Cardiovasc Surg. 2003 Jun;125(6):1481-92.

5.
6.

A single preoperative oral dose of valdecoxib, a new cyclooxygenase-2 specific inhibitor, relieves post-oral surgery or bunionectomy pain.

Desjardins PJ, Shu VS, Recker DP, Verburg KM, Woolf CJ.

Anesthesiology. 2002 Sep;97(3):565-73.

PMID:
12218521
7.

[The specific cox-2 inhibitor valdecoxib provides effective analgesia after inguinal hernia surgery].

Torres LM, Cabrera J, Martínez J, Calderón E, Fernández S, Chaves J.

Rev Esp Anestesiol Reanim. 2004 Dec;51(10):576-82. Spanish.

PMID:
15641602
8.

Reduction in opioid-related adverse events and improvement in function with parecoxib followed by valdecoxib treatment after non-cardiac surgery: a randomized, double-blind, placebo-controlled, parallel-group trial.

Langford RM, Joshi GP, Gan TJ, Mattera MS, Chen WH, Revicki DA, Chen C, Zlateva G.

Clin Drug Investig. 2009;29(9):577-90. doi: 10.2165/11317570-000000000-00000.

PMID:
19663520
9.

Effective treatment of laparoscopic cholecystectomy pain with intravenous followed by oral COX-2 specific inhibitor.

Joshi GP, Viscusi ER, Gan TJ, Minkowitz H, Cippolle M, Schuller R, Cheung RY, Fort JG.

Anesth Analg. 2004 Feb;98(2):336-42, table of contents.

PMID:
14742366
10.

Effects of valdecoxib in the treatment of chronic low back pain: results of a randomized, placebo-controlled trial.

Coats TL, Borenstein DG, Nangia NK, Brown MT.

Clin Ther. 2004 Aug;26(8):1249-60.

PMID:
15476906
11.

Valdecoxib is more efficacious than rofecoxib in relieving pain associated with oral surgery.

Fricke J, Varkalis J, Zwillich S, Adler R, Forester E, Recker DP, Verburg KM.

Am J Ther. 2002 Mar-Apr;9(2):89-97.

PMID:
11897923
12.
13.

Parecoxib sodium has opioid-sparing effects in patients undergoing total knee arthroplasty under spinal anaesthesia.

Hubbard RC, Naumann TM, Traylor L, Dhadda S.

Br J Anaesth. 2003 Feb;90(2):166-72.

PMID:
12538372
15.
17.

Effect of parecoxib on postoperative pain after lumbar spine surgery: a bicenter, randomized, double-blinded, placebo-controlled trial.

Jirarattanaphochai K, Thienthong S, Sriraj W, Jung S, Pulnitiporn A, Lertsinudom S, Foocharoen T.

Spine (Phila Pa 1976). 2008 Jan 15;33(2):132-9. doi: 10.1097/BRS.0b013e3181604529.

PMID:
18197096
18.

Safety and efficacy of the cyclooxygenase-2 inhibitors parecoxib and valdecoxib after noncardiac surgery.

Nussmeier NA, Whelton AA, Brown MT, Joshi GP, Langford RM, Singla NK, Boye ME, Verburg KM.

Anesthesiology. 2006 Mar;104(3):518-26.

PMID:
16508400
19.

Incidence of gastroduodenal ulcers associated with valdecoxib compared with that of ibuprofen and diclofenac in patients with osteoarthritis.

Sikes DH, Agrawal NM, Zhao WW, Kent JD, Recker DP, Verburg KM.

Eur J Gastroenterol Hepatol. 2002 Oct;14(10):1101-11.

PMID:
12362101
20.

Efficacy of oral rofecoxib versus intravenous ketoprofen as an adjuvant to PCA morphine after urologic surgery.

Cabrera MC, Schmied S, Derderian T, White PF, Vega R, Santelices E, Verdugo F.

Acta Anaesthesiol Scand. 2004 Oct;48(9):1190-3.

PMID:
15352968

Supplemental Content

Support Center